Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study
Journal of Gynecologic Oncology · 2026
DOI: 10.3802/jgo.2026.37.e41 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Elena Riggenbach und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. riggenbach.elena@gmail.com. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: Combining cisplatin and gemcitabine (CG) in the concurrent and adjuvant treatment phase of advanced cervical cancer has improved oncological outcome at the cost of excess toxicity. We aimed to investigate the feasibility and safety of this treatment intensification in the era of modern radiotherapy. METHODS: A retrospective review was performed on patients treated with definitive chemoradiation including CG for advanced cervical cancer. Treatment consisted of chemoradiotherapy (weekly cisplatin 40 mg/m² and gemcitabine 125 mg/m² with volumetric-modulated arc therapy) followed by image-guided adaptive brachytherapy and 2 cycles of adjuvant CG. RESULTS: Fifty-five patients were included with a median follow-up of 48 months (range, 7-130). Patients with FIGO stage IIIC1 accounted for 49.1% of cases, with an additional 23.6% being stage IIIC2. The median number of concurrent gemcitabine and cisplatin administrations was 4 (range, 1-6), and 5 (range, 2-8), respectively. Forty-four patients (80%) received adjuvant chemotherapy. Hematological severe short-term toxicity (grade ≥3) occurred in 22 patients (43.1%). There was no deviation from planned radiotherapy-schedule. No treatment-related death occurred. Five patients experienced late grade ≥3 adverse events. Local, locoregional and distant control rates at 5 years were 82.0%, 70.5% and 69.3%, respectively. Five-year progression-free survival was 50.9% and overall survival was 70.9%. CONCLUSION: Concurrent chemoradiation with CG followed by image-guided adaptive brachytherapy and adjuvant CG is feasible and associated with a lower toxicity profile than previously reported. Further research is needed to refine patient selection for different treatment intensification strategies in advanced cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. riggenbach.elena@gmail.com.
- Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
- Department of Obstetrics and Gynecology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
- Department of Medical Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
ORCID-Profile: Elena Riggenbach, Lucas Mose, Sara Imboden, Franziska Siegenthaler, Elke Krause, Flurina Anna-Carina Maria Saner, Marcela Blatti, Manuela Rabaglio, Kristina Lössl, Julian Wampfler
Zitieren
APA
Riggenbach, E., Mose, L., Imboden, S., Siegenthaler, F., Krause, E., Saner, F. A. M., Blatti, M., Rabaglio, M., Lössl, K., & Wampfler, J. (2026). Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e41
Vancouver
Riggenbach E, Mose L, Imboden S, Siegenthaler F, Krause E, Saner FAM, et al. Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e41
BibTeX
@article{Riggenbach2026,
author = {Riggenbach, Elena and Mose, Lucas and Imboden, Sara and Siegenthaler, Franziska and Krause, Elke and Saner, Flurina Anna-Carina Maria and Blatti, Marcela and Rabaglio, Manuela and Lössl, Kristina and Wampfler, Julian},
title = {Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study},
journal = {Journal of Gynecologic Oncology},
year = {2026},
doi = {10.3802/jgo.2026.37.e41}
}
EUVIMED